Summary
HCA Healthcare, Inc. (HCA) filed an 8-K on September 21, 2011, to report on significant corporate actions. The company completed a substantial share repurchase of approximately 15.6% of its outstanding common stock from affiliates of Bank of America Corporation (BAML) at $18.61 per share. This repurchase was funded by a mix of existing cash and credit facilities, indicating a strategic financial maneuver to reduce outstanding shares and potentially enhance shareholder value. In conjunction with the share repurchase, HCA also amended its Stockholders' Agreement. Notably, the BAML investors were released from the agreement, signifying a shift in the company's investor base and board composition. Consequently, three BAML-designated directors resigned from the board, reducing its size. These actions collectively represent a significant event for HCA, impacting its capital structure, investor relations, and corporate governance.
Key Highlights
- 1HCA completed a share repurchase of 80,771,143 shares from Bank of America affiliates, representing approximately 15.6% of outstanding common stock.
- 2The repurchase price was $18.61 per share, matching the closing price on September 14, 2011.
- 3The transaction was financed through a combination of cash on hand and borrowings under existing credit facilities.
- 4An amendment to the Stockholders' Agreement removed BAML investors as parties, releasing them from associated rights and obligations.
- 5Three BAML-designated directors resigned from HCA's Board of Directors.
- 6The size of HCA's Board of Directors was reduced from fifteen to twelve members following the director resignations.